CORESTATE Capital Stock Forecast, Price & News

-0.04 (-0.32 %)
(As of 07/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume46,256 shs
Average VolumeN/A
Market Capitalization$323.13 million
P/E RatioN/A
Dividend Yield13.51%
30 days | 90 days | 365 days | Advanced Chart
Receive CCAP News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

CORESTATE Capital logo

About CORESTATE Capital

CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.84 out of 5 stars

Analyst Opinion: 3.1Community Rank: 3.8Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

CORESTATE Capital (ETR:CCAP) Frequently Asked Questions

Is CORESTATE Capital a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CORESTATE Capital in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CORESTATE Capital stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CCAP, but not buy additional shares or sell existing shares.
View analyst ratings for CORESTATE Capital
or view top-rated stocks.

What stocks does MarketBeat like better than CORESTATE Capital?

Wall Street analysts have given CORESTATE Capital a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CORESTATE Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is CORESTATE Capital's next earnings date?

CORESTATE Capital is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for CORESTATE Capital

How has CORESTATE Capital's stock been impacted by COVID-19 (Coronavirus)?

CORESTATE Capital's stock was trading at €38.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CCAP shares have decreased by 67.1% and is now trading at €12.59.
View which stocks have been most impacted by COVID-19

Is CORESTATE Capital a good dividend stock?

CORESTATE Capital pays an annual dividend of €2.50 per share and currently has a dividend yield of 13.51%. CCAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View CORESTATE Capital's dividend history.

What price target have analysts set for CCAP?

5 brokerages have issued 1 year target prices for CORESTATE Capital's shares. Their forecasts range from €14.00 to €38.00. On average, they expect CORESTATE Capital's share price to reach €23.80 in the next year. This suggests a possible upside of 89.0% from the stock's current price.
View analysts' price targets for CORESTATE Capital
or view top-rated stocks among Wall Street analysts.

Who are CORESTATE Capital's key executives?

CORESTATE Capital's management team includes the following people:
  • Mr. Rene Parmantier, Chairman of Management Board & CEO (Age 46)
  • Ms. Silke Hechle, Founder
  • Mr. Christine Winter, Founder
  • Mr. Daniel Lohken, Chief Legal & HR Officer and Member of Management Board (Age 43)
  • Dr. Florian Sander, Chief Operating Officer
  • Mr. Nils Huebener, Chief Investment Officer & Member of Management Board
  • Mr. Sebastian Ernst, Chief Debt Investment Officer & Member of Management Board
  • Mr. Johannes Marklin, Chief Debt Financing Officer & Member of Management Board
  • Dr. Kai Gregor Klinger, Chief Markets Officer
  • Ms. Kathrin Aigner, Chief Compliance Officer

Who are some of CORESTATE Capital's key competitors?

What other stocks do shareholders of CORESTATE Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CORESTATE Capital investors own include Lakeland Industries (LAKE), AbbVie (ABBV), Ovintiv (OVV), SIG (SHI), American Airlines Group (AAL), Apollo Investment (AINV), Aravive (ARAV), Apollo Commercial Real Estate Finance (ARI), Berry (BRY) and 41578029 (BT.L) (BT).

What is CORESTATE Capital's stock symbol?

CORESTATE Capital trades on the ETR under the ticker symbol "CCAP."

What is CORESTATE Capital's stock price today?

One share of CCAP stock can currently be purchased for approximately €12.59.

How much money does CORESTATE Capital make?

CORESTATE Capital has a market capitalization of $323.13 million and generates $184.50 million in revenue each year.

How many employees does CORESTATE Capital have?

CORESTATE Capital employs 741 workers across the globe.

What is CORESTATE Capital's official website?

The official website for CORESTATE Capital is

How can I contact CORESTATE Capital?

The company can be reached via phone at 352 26 6372 20.

This page was last updated on 7/27/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.